WSH Incorporates Drug Approval Dates from BioMedTracker for Pharma Traders
The dataset will provide all relevant and potentially market-moving event dates around drug trials and approvals.
The vendor rolled out the data into Enchilada as a "soft launch" earlier this month, following a beta test period in January with a few hedge funds and other clients to whom WSH provides XML feeds.
In addition to FDA PDUFA (Prescription Drug User Fee Act) dates, BioMedTracker also provides WSH with other relevant information, such as the date when a drug enters review by the FDA, expected approval date plus any changes to that expected date, and the final notice of approval or denial for both
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: https://subscriptions.waterstechnology.com/subscribe
You are currently unable to print this content. Please contact info@waterstechnology.com to find out more.
You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@waterstechnology.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@waterstechnology.com
More on Emerging Technologies
Academic warns of systemic risk from AI-powered trading
Strategies generated by LLMs exhibit “very strange, correlated trading behavior”, says Lopez Lira.
Anthropic partners with S&P, TT to build AI hub, Talos acquires Coin Metrics, and more
The Waters Cooler: Bloomberg adopts agentic AI, DSB report homes in on fairer data costs, and asset managers are coming for your utilities in this week’s news roundup.
The Model Context Protocol brings agents to life—along with risk
Waters Wrap: From chat to infrastructure modernization, Anthropic’s MCP offers a ‘bridge’ to agentic AI, but its early days may prove disillusioning.
BofA ramps up AI deployment, patents
The bank has 1,400 patents in AI and machine learning, either granted or pending, alongside a growing portfolio of 250 models.
BNY CEO updates on ‘platform’ operating model, AI rollout
In its Q2 earnings call, the bank outlined its progress on rolling out its new operating model and ‘Eliza’ internal AI assistant.
NZX outlines plans to bolster fast-growing dark pool
Since launching one year ago, NZX’s dark book has 5.5% of the exchange’s total turnover, and price improvement per trade on average is 11 basis points, but the exchange has more in store.
Waters Wavelength Ep. 325: Octaura’s Brian Bejile
The CEO joins the podcast to talk about the vendor’s modernization efforts in credit and CLOs.
Agentic AI comes to Bloomberg Terminal via Anthropic protocol
The data giant’s ubiquitous terminal has been slowly opening up for years, but its latest enhancement represents a forward leap in what CTO Shawn Edwards calls, “the way we should talk to the world.”
